Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As awareness grows among both patients and healthcare providers, companion nutrition is increasingly becoming an essential part of the overall treatment journey rather than an optional add-on
Legislation is working to catch up New York leaders are advancing legislation that would dramatically expand access to obesity treatment
What factors of GLP-1 coverage drive up premiums Using data from MarketScan and research by Blue Health Intelligence (BHI), the EBRI report models how GLP-1 coverage could affect employer-sponsored insurance premiums, exploring several scenarios based on: Drug pricing Net costs range from $617 to $766 per 30-day supply Patient adherence Perfect adherence leads to higher premiums due to sustained drug use Eligibility criteria Including overweight individuals with at least one weight-related condition significantly increases cost burden Cost-sharing Cost-sharing structures such as $90 copays help but dont eliminate increases Usage is growing More than 57 million privately insured adults qualify for GLP-1 drugs, like Ozempic and Wegovy
What a legitimate COA must contain Pricing reality check Pharmaceutical-grade synthetic peptide raw material is not cheap
US$ 21.46
US$ 28.19
US$ 27.28
